What are BridgeBio Pharma's profit margins?

BridgeBio Pharma (BBIO) runs a 95.1% gross margin and a -90.5% operating margin, with a -125.9% net margin.

Where do BridgeBio Pharma's ratios come from?

Every ratio is computed from BridgeBio Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

BridgeBio Pharma BBIO Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	95.8%-2.4pp	98.3%+24.5pp	73.7%-21.9pp	95.6%-0.5pp
Operating margin	-104.2%+163pp	-267.2%+6,262pp	-6,528.8%-5,869pp	-659.6%+167pp
Net margin	-146%+98.9pp	-244.9%+6,777pp	-7,021.9%-6,398pp	-624.2%+217pp
EBITDA margin	-103.2%+161pp	-264.5%+6,194pp	-6,458.9%-5,808pp	-650.9%+168pp
Free cash flow margin	-89%—	——	-5,686.6%-5,140pp	-546.5%+187pp
Returns
Return on assets	-79%-4.9pp	-74.1%+37.6pp	-111.7%-52.5pp	-59.3%+9.1pp
Efficiency
Asset turnover	0.5×+0.2×	0.3×+0.3×	0×-0.1×	0.1×0.0×
Liquidity
Current ratio	2.8×-1.9×	4.7×+1.3×	3.3×-1.2×	4.5×-2.1×
Quick ratio	2.7×-2.0×	4.7×+1.3×	3.3×-1.2×	4.5×-2.1×
Cash ratio	0.6×-3.8×	4.4×+1.8×	2.6×-0.5×	3.1×+0.2×
Leverage
Debt-to-assets	0×-0.5×	0.5×-0.4×	0.8×+0.1×	0.7×+0.3×
Interest coverage	-6.6×-0.1×	-6.5×+1.0×	-7.5×-1.1×	-6.4×+6.0×
Per Share
Book value per share	-$10.89-38.1%	-$7.89+5.2%	-$8.32+2.2%	-$8.51-41.1%
Valuation
Market capitalization	$14.74B+184%	$5.19B-26.2%	$7.02B+517%	$1.14B-53.6%
Enterprise value	$14.58B+195%	$4.95B-30.4%	$7.11B+488%	$1.21B-51.9%
Price / sales	29.4×+6.0×	23.4×-732×	754.9×+740×	14.7×-20.5×
EV / sales	29×+6.7×	22.3×-742×	763.9×+748×	15.6×-20.5×
Free cash flow yield	-3%—	——	-7.5%+29.7pp	-37.3%-16.4pp
Earnings yield	-5%+5.5pp	-10.5%-1.2pp	-9.3%+33.2pp	-42.5%-18.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BridgeBio Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BridgeBio Pharma's profit margins?: BridgeBio Pharma (BBIO) runs a 95.1% gross margin and a -90.5% operating margin, with a -125.9% net margin.
Where do BridgeBio Pharma's ratios come from?: Every ratio is computed from BridgeBio Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.